Concepedia

Mathias M. Domostoj

MM

Statistics

Publications

10

Citations

748

H-Index

10

Active since

2001

Affiliations

University College London(Current)

Max-Planck-Institut für Kohlenforschung

Merck Serono S.A. (Switzerland)

Mathias M. Domostoj is an author at University College London specializing in medicinal chemistry, retrosynthetic analysis, and synthetic medicinal chemistry.

Publications per year

2001–2009

10

Publications

10

Total Synthesis of Dictyodendrin B

Alois Fürstner, Mathias M. Domostoj, Bodo Scheiper · Journal of the American Chemical Society · 2005 · 110 citations

, , +17

Total Syntheses of the Telomerase Inhibitors Dictyodendrin B, C, and E

Alois Fürstner, Mathias M. Domostoj, Bodo Scheiper · Journal of the American Chemical Society · 2006 · 109 citations

, , +15

Enantiospecific Formal Total Synthesis of the Tumor and GSK-3β Inhibiting Alkaloid, (−)-Agelastatin A

Karl J. Hale, Mathias M. Domostoj, Derek A. Tocher et al. · Organic Letters · 2003 · 92 citations

, , +10

Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation

Charlene Mason, Suzanne McFarlane, Patrick G. Johnston et al. · Molecular Cancer Therapeutics · 2008 · 92 citations · Full text

, , +16

Glycogen Synthase Kinase 3 Is a Potential Drug Target for African Trypanosomiasis Therapy

Kayode K. Ojo, J. Robert Gillespie, Aaron Riechers et al. · Antimicrobial Agents and Chemotherapy · 2008 · 92 citations · Full text

, , +15

1–5 of 10